Anemia management under a bundled payment policy for dialysis: A preview for the United States from Japan

Kidney International

Volumn 79, Issue 3, 2011, Pages 265-267

  Wish, Jay B ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; IRON;

ANEMIA; CHRONIC KIDNEY DISEASE; COST CONTROL; DRUG COST; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; JAPAN; KIDNEY FAILURE; MEDICARE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; QUALITY OF LIFE; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; REVIEW; UNITED STATES;

EID: 78651384385     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.459     Document Type: Note

References (10)

1. Pizzi LT, Bunz TJ, Coyne DW et al. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation . Kidney Int 2008; 74 : 1558-1595 .
2. Wish JB. Past, present and future of chronic kidney disease anemia management in the United States. Adv Chronic Kidney Dis 2009; 16: 101-108 .
3. Besarab A, Reyes CM, Hornberger J . Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients . Am J Kidney Dis 2002; 40 : 439-446 .
4. National Kidney Foundation . KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease . Am J Kidney Dis 2006; 47 (Suppl 3) : S1-S145 .
5. Kilpatrick RD, Critchlow CW, Fishbane S et al. Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients . Clin J Am Soc Nephrol 2008; 3: 1077-1083.
6. Hasegawa T, Bragg-Gresham JL, Pisoni RL et al. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin . Kidney Int 2011; 79 : 340-346 .
7. United States Renal Data System . 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health: Bethesda, MD, 2009, p 340 .
8. Spiegel DM, Khan K, Krishnan M et al. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008 . Am J Kidney Dis 2010; 55 : 113-120 .
9. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease . N Engl J Med 2006; 355 : 2085-2098 .
10. Cotter D, Thamer M, Narasimhan K et al. Translating epoetin research into practice: the role of government and the use of scientific evidence . Health Aff 2006; 25 : 1249-1259 .